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Abstract
The Health and Retirement Study is a longitudinal study of US adults enrolled
at age 50 and older. We were interested in investigating the effect of a sudden large
decline in wealth on the cognitive score of subjects. Our analysis was complicated by
the lack of randomization, confounding by indication, and a substantial fraction of the
sample and population will die during follow-up leading to some of our outcomes being
censored. Common methods to handle these problems for example marginal structural
models, may not be appropriate because it upweights subjects who are more likely to
die to obtain a population that over time resembles that would have been obtained
in the absence of death. We propose a refined approach by comparing the treatment
effect among subjects who would survive under both sets of treatment regimes being
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considered. We do so by viewing this as a large missing data problem and impute the
survival status and outcomes of the counterfactual. To improve the robustness of our
imputation, we used a modified version of the penalized spline of propensity methods
in treatment comparisons approach. We found that our proposed method worked well
in various simulation scenarios and our data analysis.
Keywords: Bayesian additive regression trees; Causal inference; Confounding by in-
dication; Longitudinal Study; Missing data; Penalized spline of propensity methods in treat-
ment comparisons.
1 Introduction
Late middle age adults commonly experience chronic health conditions like high blood pres-
sure or diabetes as well as declining cognitive abilities. Factors known to be associated
with accelerated decrease in cognitive abilities include smoking, high alcohol consumption,
physical inactivity, high dietary intake of sodium and saturated fats, low dietary intake
of fruits and vegetables (Lee et al., 2010; Stuck et al., 1999); hypertension, elevated serum
cholesterol, diabetes, obesity, cerebrovascular and cardiovascular disease (Plassman et al.,
2010); depression, lower socioeconomic status, and exposure to acute stressful life events
and chronic perceived stress (Krieger, 2001). In particular, the acute stress of a sudden
decrease in wealth – “a negative wealth shock” – may have a negative impact on the cog-
nitive ability of late middle aged adults. Because income typically exceeds consumption
at this stage in life, sudden decreases in wealth during this period not only decrease the
amount of wealth saved for retirement, but there are fewer remaining years left to replenish
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the lost wealth (Butrica et al., 2010). The stress of losing substantial wealth during the
savings period of the life cycle coupled with the pressure to replenish the lost wealth can
lead to stress-related health conditions which in turn reduces the cognitive ability of an in-
dividual (Shrira et al., 2011). In addition, individuals who have received a negative wealth
shock may have to reduce consumption of health-enhancing goods and services which in turn
leads to poor management of existing chronic conditions, further reducing cognitive abilities
(Friedman, 1956).
Three issues arise when trying to estimate the causal effect of a negative wealth shock
on cognitive ability. The first of these is the lack of randomization: negative wealth shocks
are not randomly distributed in the population, but rather are confounded by factors such
as gender and socio-economic status. The second issue is confounding by indication: the risk
of the wealth shock at any point in time may depend on the prior cognitive ability up to the
point. Finally, a sufficiently large fraction of the sample and the population will die during
our follow-up, leading to “censoring by death”. Those observed to have survived a negative
wealth shock include those who would survive under either condition together with those
that would survive only if they experienced a negative wealth shock (if any), while those
observed to have survived in the absence of a negative wealth shock include those that would
survive under either condition together with those that would survive only in the absence
of a negative wealth shock. These “missing values” associated with cognition among the
deceased are different from the measure of cognition being “missing” due to dropout, where
the cognitive ability measure exists but is unobserved. As with wealth shock, death is not
a random occurrence, and is positively associated with demographic measures that increase
the risk of a negative wealth shock, increased cognitive ability decline, and the experience
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of a negative wealth shock. Hence, the measure for cognitive ability may be confounded by
death if not considered appropriately.
Methods have been developed to deal with these barriers to causal inference. To deal
with the lack of randomization, we might hope that, conditional on available covariates,
negative wealth shocks would truly be random. In this case, conditioning on the probability
of receiving a negative wealth shock as a function of these covariates – the propensity scores
(Rosenbaum and Rubin, 1983) – can be used to remove the effect of confounding, either by
regression, matching, or weighting (Imbens and Rubin, 2015). For the second issue – con-
founding by indication – marginal structural models (MSM, Robins et al., 2000) and more
recently, penalized spline of propensity methods in treatment comparisons (PENCOMP,
Zhou et al., 2018), have been used to account for confounding by the time-dependence as-
sociation of the cognitive measures, either by weighting using the inverse probability of
treatment actually received based on the previous values of the time-varying covariates and
outcomes (MSM), or by imputation of the missing counterfactual values (PENCOMP). For
censoring by death, MSMs have typically been extended by multiplying the treatment as-
signment weights with the inverse of the predicted probability of death (Weuve et al., 2012).
The issue with this approach – perhaps under appreciated – is that the resulting pseudo-
population is not only balanced with respect to exposure “assignment”, but also “immortal”,
in the sense that those more likely to die are upweighted so that the population over time
resembles that would have been obtained in the absence of death up till time t (Chaix et al.,
2012). This is arguably not a sensible population for inference, at least from a policy and
public health perspective.
A more refined approach would be to compare the difference in the effect of negative
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wealth shock on cognitive ability among subjects who would have survived whether they
experienced a negative wealth shock or not. This approach is consistent with the potential
outcomes approach of Neyman (1934) and Rubin (1974), which defines causal effects as the
within-subject difference of an outcome at a particular time under different exposure or
treatment regimen, averaged over the population. This idea is not new (Elliott et al., 2006)
and can be viewed as a specific example of the principal stratification (PS) method discussed
in Frangakis and Rubin (2002). Our innovation here is to embed this in a longitudinal setting
where confounding by indication is present. We view this as a large missing data problem
where survival status and, among survivors, unobserved outcomes under a given treatment
pattern, are imputed. We extend the method proposed in Example 3 of Elliott and Little
(2015), which provides a Bayesian MSM approach to compare two treatments at two time
points. This approach was further extended by PENCOMP in Zhou et al. (2018) which, like
augmented inverse probability weighting (AIPWT, Robins et al., 1994), has a doubly-robust
property in that if either the mean or propensity model is correctly specified, consistent
estimates of the causal effect will be obtained. We modified PENCOMP slightly using
Bayesian additive regression trees (BART), a flexible model to ease the burden of model
specification by the researcher, and apply this to our proposed method.
We organize our paper as follows. We set up the framework for our problem, and pro-
vide a brief review of of MSM, PENCOMP, and Bayesian additive regression trees (BART)
in Section 2. We develop our proposed method in Section 3. We then explore some of the
empirical properties of our proposed method compared to a na¨ıve method and MSM using
a simulation study in Section 4. Section 5 describes the HRS data and the results of our
negative wealth shock analysis. Section 6 concludes with a discussion of the implication of
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our results as well as future work.
2 Review of Relevant Methods
2.1 Setup and notation
Let V = {V1, V2, . . . , Vp} be p baseline covariates, Zt be the treatment allocation at time
t = 1, . . . , T where Zt = 1 indicates a subject receiving a negative wealth shock at t and
Zt = 0 indicates no negative wealth shock, and Wt = {W1t,W2t, . . . ,Wqt} be q covariates
that may vary with time, but are unaffected by a given treatment regimen. For exam-
ple, fixed covariates by definition would belong to this class. Let YZ1,...,Zt be the potential
outcome under treatments Z1, . . . , Zt and XZ1,...,Zt = {XZ1,...,Zt,1, XZ1,...,Zt,2, . . . , XZ1,...,Zt,r}
be the time-varying covariates affected by treatments Z1, . . . , Zt. Similarly, we define the
potential survival indicator SZ1,...,Zt−1, for survival at time t. The survival outcome at t
measures whether a subject would survive after being exposed to treatment Z1, . . . , Zt−1;
hence, the lagged notation for the potential survival outcome, SZ1,...,Zt−1. v, zt, wt, yz1,...,zt ,
xz1,...,zt , and sz1,...,zt indicate the observed baseline, treatment allocation, time varying covari-
ates unaffected by a given treatment regimen, outcome, time-varying covariates affected by
a given treatment regime, and survival status variables respectively. As in Pool et al. (2018),
we assume that a negative wealth shock is an “absorbing state” so that once a subject re-
ceives a negative wealth shock at time t, i.e. Zt = 1, the subject is “forever” shocked, i.e.
Zt+1 = . . . = ZT = 1. Note that this need not be the case for a more general set up where
we could have Zt = 0 when Zj = 1 for any j = 1, . . . , t − 1. In our context, the potential
outcomes for time t = 2 are then YZ1=0,Z2=0 = Y00, YZ1=0,Z2=1 = Y01, and YZ1=1,Z2=1 = Y11;
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similarly, XZ1=0,Z2=0 = X00, XZ1=0,Z2=1 = X01, and XZ1=1,Z2=1 = X11 for time-varying co-
variates under the various treatment regimes; and SZ1=0 = S0, SZ1=1 = S1 for survival states.
Subjects who die at time t have structurally missing data for outcomes and covariates i.e.,
S0 = 0 implies that Y00 = Y01 = NA and X00 = X01 = NA, while S1 = 0 implies that
Y11 = NA and X11 = NA, where ‘NA’ indicates a structurally missing observation.
2.2 Marginal structural model
To estimate the causal effect for confounding by indication and censoring by death problems,
MSM makes the following assumptions. First, MSM assumes that
P (Sz1,...,zt−1|z1, . . . , zt−1, yz1, . . . , yz1,...,zt−1, xz1, . . . , xz1,...,zt−1, w1, . . . , wt−1, v) > 0. (1)
and
P (Zt|z1, . . . , zt−1, yz1, . . . , yz1,...,zt−1, xz1 , . . . , xz1,...,zt−1, w1, . . . , wt−1, v) > 0 (2)
for any zt i.e. the probability of survival under treatment profile z1, . . . , zt−1 and the prob-
ability of treatment allocation for time t is bounded away from 0. This is an extension of
the standard positivity assumption to allow that at least some subjects will survive under a
given treatment regimen. Second, MSM assumes that there is no interference between sub-
jects i.e. the potential outcome of subject i, Yi,Z1,...,Zt = Yi,z1,...,zt , is independent of whatever
treatment regimen subject j is allocated to i 6= j. Third, MSM assumes no unmeasured
confounding and sequential randomization condition
YZ1,...,Zt⊥Zt|z1, . . . , zt−1, yz1,...,zt−1, . . . , yz1, xz1,...,zt−1, . . . , xz1 , w1, . . . , wt−1, v.
Finally, MSM assumes that the model specifications for Equations 1, 2, and
Yz1,...,zt|z1, . . . , zt, yz1,...,zt−1, . . . , yz1, xz1,...,zt−1, . . . , xz1, w1, . . . , wt−1, v
7
are correct.
With these assumptions in place, E[Yz1,...,zt − Yz′1,...,z′t] (note that this estimand is not
conditioned on the survival status) is obtained by maximizing the weighted likelihood of
n∏
i=1
f(Yi;z1,...,zt|θit)wit , (3)
where i indexes the subjects and θit are the parameters involved in the model for Yi;z1,...,zt
and
wit = [
t∏
j=1
P (Zij = zij|zi1, . . . , zi,j−1, yi1, . . . , yi,j−1, xi1, . . . , xi,j−1, wi1, . . . , wi,j−1, vi; τj)]−1. (4)
By weighting using the inverse probability of receiving the observed treatment regime given
all covariates and previous treatments, the association between treatment and all observed
confounders, including confounding by indication, are broken. Under these four assump-
tions, inference about the treatment effects under a pseudo-population in which treatment
is randomized can then be obtained.
Similarly, this weighting method can be used to remove bias due to dropout. Let Ri = 1
indicate that the subject’s cognitive score is observed and Ri = 0 indicate that the subject’s
cognitive score is missing. The weight used to account for missing cognitive score is
writ = [
t∏
j=1
P (Rij = rij |ri1, . . . , ri,j−1, zi1, . . . , zi,j−1, yi1, . . . , yi,j−1, xi1, . . . , xi,j−1, wi1, . . . , wi,j−1, vi; γj)]−1. (5)
Finally, death is typically treated as equivalent to dropout in MSM (Do et al., 2013;
Pool et al., 2018). Let Dit = 1 indicate that subject i is dead at time t and Dit = 0 indicate
that the subject survived at time t (thus Dit = 1 − Sit). The weight for death censoring is
then
wdit = [
t∏
j=1
P (Dij = dij |zi1, . . . , zi,j−1, yi1, . . . , yi,j−1, xi1, . . . , xi,j−1, wi1, . . . , wi,j−1, vi;λj)]−1. (6)
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Assuming that these three weights are independent of each other, the final weight that
we used becomes wfit = witw
d
itw
r
it. To stabilize the weights, the numerators of Equations
4, 5, and 6 are replaced by the marginal probabilities of treatment, dropout, and death at
baseline given by
t∏
j=1
P (Zij = zij |zi1, . . . , zi,j−1, vi; τ ′j),
t∏
j=1
P (Rij = rij|ri1, . . . , ri,j−1, vi; γ′j),
and
t∏
j=1
P (Dij = dij|vi;λ′j)
respectively. We use the stabilized weights in our simulations and analysis.
2.3 Penalized Spline of Propensity Methods for Treatment Com-
parison
PENCOMP uses the same four assumptions made by MSM excluding Equation 1 for con-
founding by indication problems. Full details of PENCOMP can be found in Zhou et al.
(2018). We briefly describe the algorithm for PENCOMP using multiple imputation (MI)
with longitudinal treatment assignments here. Without loss of generality, we assume no
time-varying covariates in the data.
1. For b = 1, . . . , B, generate a bootstrap sample S(b) from the original data S by sampling
units with replacement, stratified on treatment group. For each sample b, carry out
steps 2-7.
2. Estimate a logistic regression model for the distribution of Z1 given baseline covariates
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V with regression parameters γz1. Estimate the propensity to be assigned treatment
Z1 = z1 as Pˆz1(V ) = Pr(Z1 = z1|V ; γˆbz1), where γˆbz1 is the maximum likelihood (ML)
estimate of γz1. Define Pˆ
∗
z1
= log[
Pˆz1(V )
1−Pˆz1 (V )
].
3. Using the cases assigned to treatment group Z1 = z1, estimate a normal linear regres-
sion of Yz1 on V , with mean
E(Yz1|V, Z1 = z1, θz1 , βz1) = s(Pˆ ∗z1 |θz1) + gz1(Pˆ ∗z1, V ; βz1), (7)
where s(Pˆ ∗z1 |θz1) denotes a penalized spline with fixed knots and parameters θz1 and
gz1(.) represents a parametric function of other predictors of the outcome, indexed by
parameters βz1 . One of the covariates might be omitted to avoid collinearity in the
covariates in Equation 7.
4. For z1 = 0, 1, impute the values of Yz1 for subjects in treatment group 1 − z1 in
the original data with draws from the predictive distribution of Yz1 given V from the
regression in Step 3, with the ML estimates θˆ
(b)
z1 , βˆ
(b)
z1 substituted for the parameters
θ
(b)
z1 , β
(b)
z1 .
5. Estimate a logistic regression model for the distribution of Z2 given V, Z1, (Y0, Y1),
with regression parameters γz2 and missing values of (Y0, Y1) imputed from Step 4.
Estimate the propensity to be assigned treatment Z2 = z2 given Z1, YZ1, and V as
Pˆz2(Z1, YZ1, V ) = Pr(Z2 = z2|Z1 = z1, Yz1, V ; γˆ(b)z2 ), where γˆ(b)z2 is the ML estimate of
γz2. The probability of treatment regimen (Z1 = z1, Z2 = z2) is denoted as Pˆz1z2 =
Pˆz1(V )Pˆz2(Z1, YZ1, V ), and define Pˆ
∗
z1,z2
= log[
Pˆz1z2
1−Pˆz1z2
].
6. Using the cases assigned to treatment group (z1, z2), estimate a normal linear regression
of Yz1,z2 on Z2, Z1, YZ1, and V with mean
E(Yz1,z2 |V, Yz1 , Z1 = z1, Z1 = z2, θz1,z2 , βz1,z2) = s(Pˆ ∗z1,z2 |θz1,z2) + gz1,z2(Pˆ ∗z1,z2 , Z2, Z1, YZ1 , V ; βz1,z2 ). (8)
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7. For each combination of (z1, z2) impute the values of Yz1,z2 for subjects not assigned
this treatment combination in the original data with draws from the predictive distri-
bution of Yz1,z2 in Step 6, with ML estimates θˆ
(b)
z1,z2, βˆ
(b)
z1,z2 substituted for the parameters
θ
(b)
z1,z2, β
(b)
z1,z2. Let ∆ˆ
(b)
01,00 = E[Y01−Y00], ∆ˆ(b)11,00 = E[Y11−Y00], and ∆ˆ(b)11,01 = E[Y11− Y01]
denote the average treatment effects, ∆ˆ
(b)
jk,lm, with associated pooled variance estimates
W
(b)
jk,lm, based on the observed and imputed values of Y for each treatment regimen.
8. The MI estimate of ∆jk,lm is then ∆¯jk,lm,B =
∑B
b=1 ∆ˆ
(b)
jk,lm, and the MI estimate
of the variance of ∆¯jk,lm is TB = W¯jk,lm,B + (1 + 1/B)Djk,lm,B, where W¯jk,lm,B =
∑B
b=1W
(b)
jk,lm/B, Djk,lm,B =
∑B
b=1
(∆ˆ
(b)
jk,lm
−∆¯jk,lm,B)2
B−1 . The estimate ∆jk,lm follows a t
distribution with degree of freedom ν,
∆jk,lm−∆¯jk,lm,B√
TB
∼ tν , where ν = (B − 1)(1 +
W¯jk,lm,B
Djk,lm,B(B+1)
)2.
2.4 Bayesian additive regression trees
BART (Chipman et al., 2010) is a flexible estimation technique for any arbitrary function.
Suppose we have a continuous outcome Y and corresponding p predictors X = (X1, . . . , Xp).
Suppose Y is related to X via
Y = f(X) + e (9)
where f(.) is any arbitrary function which could involve complicated non-linear and multiple-
way interactions and e ∼ N(0, σ2). Formally, BART is written as
Y =
m∑
j=1
g(X, Tj,Mj) + e (10)
where (Tj ,Mj) is the joint distribution of the j
th binary tree structure Tj with its corre-
sponding bj terminal node parameters Mj = (µ1j, . . . , µbjj). m is the number of regression
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trees used to estimate f(X) and it is usually fixed at 200.
BART is able to model multiple-way interactions by using regression trees. In essence,
a binary regression tree in BART may be viewed as a penalized form of an Analysis of
Variance (ANOVA) model. When the binary regression tree only splits on one variable for
the whole tree, a main effects model is obtained. When the regression tree involve splits
on many different variables, a multiple-way interaction model is obtained. BART combines
all m regression trees together in an additive manner to obtain non-linear estimates of the
main and interaction effects. This additive procedure is done by first ‘breaking’ Y into m
equal ‘pieces’ and fitting a regression tree to each piece. Subsequently, the regression tree
in each m piece is then estimated by looking at the residual produced by the other m − 1
most updated regression trees. MCMC procedures are then used to obtain the posterior
distribution of f(X). When the default priors of BART suggested by Chipman et al. (2010)
are assumed, the MCMC ensures that the eventual distribution of the the sum of regression
trees is concentrated around the true distribution of the model (Rockova and van der Pas,
2017).
For binary outcomes, BART uses a probit link where
P (Y = 1|X) = Φ(
m∑
j=1
g[X, Tj,Mj]) (11)
where Φ(.) is the cdf of a standard normal distribution. Estimation of the posterior dis-
tribution is similar to that of continuous outcomes but with the use of data augmentation
methods, i.e. draw a continuous latent variable based on whether Y = 1 or Y = 0 and then
run the BART algorithm on the drawn latent variables.
Kapelner and Bleich (2015) suggested a procedure to allow the BART algorithm to
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include covariates that might contain missing values. In brief, the missingness in the co-
variates are not imputed but instead, viewed as a ‘value level’ in the MCMC algorithm.
The MCMC algorithm then ‘sends’ missing data to terminal nodes in the regression trees
that would maximize the likelihood. This is termed as “Missing Incorporated in Attributes”
(MIA, Twala et al., 2008, Section 2). Kapelner and Bleich (2015) showed using simulation
examples that incorporating MIA within BART allows the appropriate handling of different
types of missing mechanism, MCAR, MAR, and NMAR, for each covariate. We utilize this
approach to accommodate the missingness in our covariates for the data analysis.
3 Dealing with Censoring by Death
3.1 Determining the principal strata
To determine the principal strata definition, we first investigated what the data for our
problem could potentially look like. We constructed Table 1 for t = 3, p = 1, and no time-
varying covariates without loss of generality. In this table, ‘x’ indicates an observed value, ‘?’
represent a missing observation which needs to be imputed, and ‘NA’ indicates a structurally
missing observation. For the potential survival outcomes, we did not indicate whether they
were missing or observed because we wanted to use Table 1 to help us decide how we should
be stratifying our subjects once our proposed method imputes the counterfactual survival
status.
From Table 1, we can see that the goal of our analysis is to provide inference about
E[YZ1,...,Zt − YZ′1,...,Z′t |SZ1,...,Zt−1 = SZ′1,...,Z′t−1 = 1], where Zl 6= Z ′l for at least one l with l =
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1, . . . , t i.e. we condition on subjects who would potentially survive under two different treat-
ment regimes Z1, . . . , Zt−1 and Z ′1, . . . , Z
′
t−1. Thus, the distribution of (SZ1,...,Zt−1, SZ′1,...,Z′t−1)
form our principal strata and meaningful contrasts are defined only in the stratum where
SZ1,...,Zt−1 = SZ′1,...,Z′t−1 = 1 since the potential outcomes for the two different treatment
regimes exist only in this stratum. For example, if we want to estimate the effect for a nega-
tive wealth shock at t = 2 versus no negative wealth shock by t = 2 that is E[Y01−Y00|S0 = 1],
we restrict to subjects who survive if they did not receive a negative wealth shock at
t = 1 i.e. subjects with S0 = 1 (Subjects 1-12 in Table 1). Note that the definition,
E[YZ1,...,Zt − YZ′1,...,Z′t |SZ1,...,Zt−1 = SZ′1,...,Z′t−1 = 1], is different from the parameter MSM esti-
mates which is E[YZ1,...,Zt − YZ′1,...,Z′t].
3.2 Proposed method
We make the same four assumptions used by MSM (See Section 2.2). We impose a further
fifth assumption of strict monotonicity in that
IfZ1 ≤ Z ′1, Z2 ≤ Z ′2, . . . , Zt−1 ≤ Z ′t−1, Zi 6= Z ′i for any i, thenSZ1,...,Zt−1 ≥ SZ′1,...,Z′t−1. (12)
As a consequence, we have for example, when t = 2, if S0 = 0 then S1 = 0 and if S1 = 1
then S0 = 1. This means that we rule out the possibility of a subject who does not receive a
negative wealth shock and dies but would survive if having received a neagtive wealth shock.
Conversely, if a subject survives after having received a negative wealth shock, we rule out
the possibility that this same subject would die if he or she did not receive a negative wealth
shock.
Our proposed method then estimates E[YZ1,...,Zt − YZ′1,...,Z′t|SZ1,...,Zt−1 = SZ′1,...,Z′t−1 = 1]
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by imputing the survival status of each subject at the current time t and then combine the im-
puted counterfactual survival status together with the observed survival status to determine
which principal stratum a subject belongs to. We then use a slightly modified PENCOMP
to impute the counterfactual outcomes among the potentially surviving subjects to account
for the bias due to confounding by indication. This approach is doubly robust and reduces
the burden of model specification by the researcher. Subsequently, the average difference in
the treatment effect within the desired principal strata is calculated. Variance is estimated
using Rubin’s combine rule to account for the imputation uncertainty (Heitjan and Little,
1991). Detailed steps for our method are given below.
1. Generate a bootstrap sample b from the data by sampling the units with replacement.
2. Estimate the model X
(b)
z
(b)
1
|Z(b)1 = z(b)1 ,W (b)1 , V (b). Use this model to compute the coun-
terfactual of X
(b)
z
(b)
1
for bootstrap sample b.
3. Estimate the distribution of Z
(b)
1 |W (b)1 , V (b). Use this model to estimate the propensity
to be assigned treatment Z
(b)
1 = z
(b)
1 as P
∗
z
(b)
1
= Pr(Z
(b)
1 = z
(b)
1 |W (b)1 , V (b)). Note that we
did not perform a logit transformation to obtain P ∗
z
(b)
1
(See PENCOMP Steps 2 and 5).
This is because by using PENCOMP modified with BART to predict the outcomes, the
non-linear effect of the propensity of assigned treatment will be handled automatically.
Hence, any non-linear transformation on the propensity of assigned treatment would
not be needed.
4. Estimate the model Y
(b)
z
(b)
1
|P ∗
z
(b)
1
, Z
(b)
1 = z
(b)
1 , X
(b)
z
(b)
1
,W
(b)
1 , V
(b). As mentioned, we used
PENCOMP modified with BART to estimate this model. The advantage of using
BART is the researcher no longer needs to specify the model. BART automatically
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takes care of any linear or non-linear main effects as well as linear or non-linear inter-
actions. If we observe Equations 7 and 8, we can see that these two equations are con-
structed using a non-linear spline specification on the propensity of assigned treatment
combined with possible linear interactions between the propensity of assigned treat-
ment and remaining covariates. This fits well with the type of estimation problems
that BART was designed to solve. We then use the model produced by BART-modified
PENCOMP to compute the counterfactual of Y
(b)
z
(b)
1
for bootstrap sample b.
5. Estimate the distribution for S
(b)
z
(b)
1
|Z(b)1 = z(b)1 , Y (b)z(b)1 , X
(b)
z
(b)
1
,W
(b)
1 , V
(b) at t = 2. Use this
model to generate a survival status for the counterfactual of S
(b)
zb1
taking into account
the assumption of monotonicity in Equation (12) i.e. if S0 is observed and S0 = 0 then
S1 = 0. Similarly, if S1 is observed and S1 = 1 then S0 = 1.
6. Estimate the model X
(b)
z
(b)
1 ,z
(b)
2
|Z(b)1 = z(b)1 , Z(b)2 = z(b)2 , Y (b)z(b)1 , X
(b)
z
(b)
1
,W
(b)
1 ,W
(b)
2 , V
(b). Use
the respective models to impute the counterfactual of X
(b)
z
(b)
1 ,z
(b)
2
, using any previously
imputed values for the unobserved treatment regimes and restricting to the subjects
that are observed and predicted to survive under the given treatment regimen of interest
at t = 1.
7. Estimate the distribution of Z
(b)
2 |Z(b)1 = z(b)1 , Y (b)z(b)1 , X
(b)
z
(b)
1
,W
(b)
1 ,W
(b)
2 , V
(b). Use this model
to estimate the propensity to be assigned treatment Z
(b)
2 = z
(b)
2 as Pz(b)2
= Pr(Z
(b)
1 =
z
(b)
1 |X(b)z(b)1 , Z
(b)
1 = z
(b)
1 ,W
(b)
1 , V
(b)). The probability of treatment regimen (Z
(b)
1 = z
(b)
1 , Z
(b)
2 =
z
(b)
2 ) is denoted as P
∗
z
(b)
2
= P
z
(b)
2
P ∗
z
(b)
1
.
8. Estimate the model
Y
(b)
z
(b)
1 ,z
(b)
2
|P ∗
z
(b)
2
, Z
(b)
1 = z
(b)
1 , Z
(b)
2 = z
(b)
2 , Y
(b)
z
(b)
1
, X
(b)
z
(b)
1
, X
(b)
z
(b)
1 ,z
(b)
2
,W
(b)
1 ,W
(b)
2 , V
(b)
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again restricting to subjects that are observed and predicted to survive under the
treatment regimes of interest at t = 2. Use the respective models to impute the
counterfactual of Y
(b)
z
(b)
1 ,z
(b)
2
.
9. Using a similar procedure for steps 5-8 with the restriction determined by S
(b)
z
(b)
1 ,...,z
(b)
t−1
=
S
(b)
z
′(b)
1 ,...,z
′(b)
t−1
= 1 for time t where at least one z
(b)
t 6= z
′(b)
t , extend the estimation until
the desired time point t = T .
10. Repeat Steps 1-9 to obtain B bootstrap values for
∆ˆ
(b)
z
(b)
1 ,...,z
(b)
t−1,z
′(b)
1 ,...,z
′(b)
t−1
= E[Y
(b)
z
(b)
1 ,...,z
(b)
t−1
− Y (b)
z
′(b)
1 ,...,z
′(b)
t−1
|S(b)
z
(b)
1 ,...,z
(b)
t−1
= S
(b)
z
′(b)
1 ,...,z
′(b)
t−1
= 1].
with associated pooled variance W
(b)
z
(b)
1 ,...,z
(b)
t−1,z
′(b)
1 ,...,z
′(b)
t−1
.
11. The estimate of
∆Z1,...,Zt,Z′1,...,Z′t = E[YZ1,...,Zt − YZ′1,...,Z′t |SZ1,...,Zt−1 = SZ′1,...,Z′t−1 = 1]
is then
∆¯z1,...,zt,z′1,...,z′t,B =
B∑
b=1
(∆ˆ
(b)
z
(b)
1 ,...,z
(b)
t−1,z
′(b)
1 ,...,z
′(b)
t−1
)/B,
and the estimate of the variance of ∆¯z1,...,zt,z′1,...,z′t,B is
TB = W¯z1,...,zt,z′1,...,z′t,B + (1 + 1/B)Dz1,...,zt,z′1,...,z′t,B,
where
W¯z1,...,zt,z′1,...,z′t,B =
B∑
b=1
(W
(b)
z
(b)
1 ,...,z
(b)
t−1,z
′(b)
1 ,...,z
′(b)
t−1
)/B
and
Dz1,...,zt,z′1,...,z′t,B =
B∑
b=1
(∆ˆ
(b)
z
(b)
1 ,...,z
(b)
t−1,z
′(b)
1 ,...,z
′(b)
t−1
− ∆¯z1,...,zt,z′1,...,z′t,B)2
B − 1 .
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The estimate ∆Z1,...,Zt,Z′1,...,Z′t follows a t distribution with degree of freedom ν,
∆Z1,...,Zt,Z′1,...,Z′t − ∆¯z1,...,zt,z′1,...,z′t,B√
TB
∼ tν ,
where ν = (B − 1)(1 + W¯z1,...,zt,z′1,...,z′t,B
Dz1,...,zt,z
′
1,...,z
′
t
,B(B+1)
)2.
Remark. The idea of including the BART estimated propensity score within BART
as a predictor in Steps 4 and 8 is not new. Hahn et al. (2018) showed that including a
BART estimated propensity score as a predictor within BART improved the estimation of
heterogenous treatment effects for observational studies. Tan et al. (2018) also reported
that the inclusion of the BART estimated propensity score as a predictor within BART to
impute missing data, under the missing at random assumption, worked well in situations
where the non-linear main and interaction effects are complex for the mean and propensity
model. For situations with simpler non-linear effects like a quadratic relationship, using
BART to estimate the propensity score and imputing the missing values using penalized
splines of propensity prediction (Zhang and Little, 2009, PENCOMP version for missing
data) worked better. Using PENCOMP with a BART estimated propensity score for Steps
4 and 8 would be an interesting alternative. However, our aim of Steps 4 and 8 was to ease
the implementation burden on the researcher. Hence, we suggest the use of PENCOMP with
a BART estimated propensity score for Steps 4 and 8 only if the researcher is certain that
the non-linear effect has a simple form for example, a quadratic or cubic relationship.
4 Simulation
We conducted a simulation study to determine how well our proposed method would per-
form compared to the na¨ıve method and MSM in three scenarios: 1) where there is low
18
association between treatment allocation and confounder as well as treatment and survival
status; 2) where there is a strong association between treatment and confounder as well as
treatment and survival status; and finally 3) where there is a strong association between
treatment and confounder, treatment and survival status, and an interaction between treat-
ment, confounder, and survival status. We expect all three methods to perform well in the
first scenario because there is little to no confounding. For the second scenario, we expect
MSM and our proposed method to perform well because there is no difference in the treat-
ment effect between the principal strata, and other stratification groups. The na¨ıve method
should not perform well due to the strong association between treatment and confounder
as well as treatment and survival status. Finally, for scenario three, we expect only our
proposed method to perform well because an association between the treatment effect and
principal strata, SZ1,...,Zt−1 = SZ′1,...,Z′t−1 = 1, is induced by the stronger interaction effect
between treatment, confounder, and survival status. We fit standard linear and logistic re-
gression models rather than BART and PENCOMP with BART since our focus is not on
model misspecification but rather, the effect of confounding by indication and censoring by
death.
4.1 Setup
To set up our simulation study, we set the size of our target population as 1 million. We
then generate a single baseline variable V from a normal distribution. We set T = 3 and
model our treatment allocation, Z1, as
logit[P (Z1 = 1|V )] = γ0 + γ1V. (13)
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For the potential outcome at t = 1, YZ1, we model it as
YZ1 = β0 + βZI{Z1 = 1}+ βV V + βV ZV I{Z1 = 1}+ e, (14)
where e ∼ N(0, 1).
We model the potential survival status at t = 2, SZ1 as
logit(P [SZ1 = 1|V, YZ1]) = α0 + αY1Y1I{Z1 = 1}+ αY0Y0[1− I{Z1 = 1}]
+ αZI{Z1 = 1}+ αV V + αV ZV I{Z1 = 1}. (15)
Monotonicity is imposed by setting S0 = 1 if S1 = 1. Because a negative wealth shock is an
absorbing state, if Z1 = 1, then Z2 = 1. So when Z1 = 0, we have
logit(P [Z2 = 1|V, Y0]) = γ0 + γY0,2Y0 + γ2V. (16)
We model the potential outcome at t = 2, YZ1,Z2 as
YZ1,Z2 = β0 + βZ01I{Z1 = 0, Z2 = 1}+ βZ11I{Z1 = 1, Z2 = 1}
+ βY0Z00Y0I{Z1 = 0, Z2 = 0}+ βY0Z01Y0I{Z1 = 0, Z2 = 1}
+ βY1Z11Y1I{Z1 = 1, Z2 = 1}+ βV V + βV Z01V I{Z1 = 0, Z2 = 1}
+ βV Z11V I{Z1 = 1, Z2 = 1}+ e, (17)
where e ∼ N(0, 1).
For the potential survival status at t = 3, SZ1,Z2, if SZ1 = 0, then SZ1,Z2 = 0. When
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SZ1 = 1, we have
logit(P [SZ1,Z2 = 1|X, YZ1,Z2 , SZ1 = 1]) = α0 + αZ01I{Z1 = 0, Z2 = 1}
+ αZ11I{Z1 = 1, Z2 = 1}
+ αY00Z00Y00I{Z1 = 0, Z2 = 0}
+ αY01Z01Y01I{Z1 = 0, Z2 = 1}
+ αY11Z11Y11I{Z1 = 1, Z2 = 1}
+ αV V + αV Z01V I{Z1 = 0, Z2 = 1}
+ αV Z11V I{Z1 = 1, Z2 = 1}. (18)
Again, we impose monotonicity by setting S00 = S01 = 1 if S11 = 1 and S00 = 1 if S01 = 1.
For the treatment allocation at t = 3, Z3, if Z1 = Z2 = 0, we have
logit(P [Z3 = 1|X, Y00]) = γ0 + γY00Y00 + γY0,3Y0 + γ3V. (19)
For the potential outcome at t = 3, YZ1,Z2,Z3, we have
YZ1,Z2,Z3 = β0 + βZ001I{Z1 = 0, Z2 = 0, Z3 = 1}+ βZ011I{Z1 = 0, Z2 = 1, Z3 = 1}
+ βZ111I{Z1 = 1, Z2 = 1, Z3 = 1}+ βY00Z000Y00I{Z1 = 0, Z2 = 0, Z3 = 0}
+ βY00Z001Y00I{Z1 = 0, Z2 = 0, Z3 = 1}
+ βY01Z011Y01I{Z1 = 0, Z2 = 1, Z3 = 1}
+ βY11Z111Y11I{Z1 = 1, Z2 = 1, Z3 = 1}+ βY0Z0Y0I{Z1 = 0}
+ βY1Z1Y1I{Z1 = 1}+ βV V + βV Z001V I{Z1 = 0, Z2 = 0, Z3 = 1}
+ βV Z011V I{Z1 = 0, Z2 = 1, Z3 = 1}
+ βV Z111V I{Z1 = 1, Z2 = 1, Z3 = 1}+ e. (20)
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Table 2 shows the parameters we used to achieve the three different simulation sce-
narios. Scenario 1 is achieved by setting γ1, αZ , γ2, γY0,2, αZ01 , αZ11 , γ3, γY0,3, and γY00 to
be about 10 times smaller than the values in Scenarios 2 and 3. The rest of the differences
between Scenario 1 versus 2 and 3 were to ensure the resulting simulated population would
have enough deaths and subjects in the various different treatment regimes for the assump-
tions used by MSM and our proposed method to be valid. The difference between Scenario
2 versus 3 lie in βV Z , αY1 , αY0 , βY0Z00 , βY0Z01 , βY1Z11 , αY0Z00 , αY0Z01 , αY1Z11 , βY00Z000 , βY00Z001 ,
βY01Z011 , and βY11Z111 where the values for Scenario 2 is about 10 times smaller compared to
Scenario 3.
To calculate the true parameters, we used the generated population data (size 1 mil-
lion), and then took:
1. ∆1,0 = Y¯1 − Y¯0;
2. ∆01,00 = Y¯01 − Y¯00 given S0 = 1;
3. ∆11,00 = Y¯11 − Y¯00 given S0 = S1 = 1;
4. ∆11,01 = Y¯11 − Y¯01 given S0 = S1 = 1;
5. ∆001,000 = Y¯001 − Y¯000 given S00 = 1;
6. ∆011,000 = Y¯011 − Y¯000 given S00 = S01 = 1;
7. ∆111,000 = Y¯111 − Y¯000 given S00 = S11 = 1;
8. ∆011,001 = Y¯011 − Y¯001 given S00 = S01 = 1;
9. ∆111,001 = Y¯111 − Y¯001 given S00 = S11 = 1; and
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10. ∆111,011 = Y¯111 − Y¯011 given S01 = S11 = 1.
We measured performance using the empirical bias, root mean squared error (RMSE),
95% coverage, and the average 95% Confidence Interval (CI) length (AIL). 1000 simulations
were used to estimate these quantities. Under each simulation, a simple random sample of
4,000 or 8,000 subjects was drawn from the target population data. All methods were then
implemented on the sampled data to obtain the effect estimates. For MSM and our proposed
method, the models were specified using Equations 13 to 20 respectively. For our proposed
method, because our focus is not on model misspecification but rather, confounding by in-
dication and censoring by death, we chose to implement a simpler version of our method
by skipping Steps 3 and 7 of our algorithm and using Y
(b)
z
(b)
1
|Z(b)1 = z(b)1 , X(b)z(b)1 ,W
(b)
1 , V
(b) and
Y
(b)
z
(b)
1 ,z
(b)
2
|Z(b)1 = z(b)1 , Z(b)2 = z(b)2 , Y (b)z(b)1 , X
(b)
z
(b)
1
, X
(b)
z
(b)
1 ,z
(b)
2
,W
(b)
1 ,W
(b)
2 , V
(b) for Steps 4 and 8 respec-
tively. We also simplified the prediction of the potential outcomes and survival status by
using linear and logistic regression instead of BART.
4.2 Results
Table 3 shows the simulation results for sample size of 4,000. As expected, under Scenario 1,
all three methods were relatively unbiased with all three methods achieving similar RMSE.
MSM and our proposed method reported slightly greater than nominal coverage due to the
wider AIL. Under Scenario 2, the absolute bias of the na¨ıve method was always larger than
MSM and our proposed method. RMSE was larger as well in comparison and coverage
was often far below the nominal 95% value. For this scenario MSM produced the less
conservative coverage while our proposed method suggested better bias performance and
reduced RMSE. Finally, under Scenario 3, the na¨ıve method was clearly biased with poor
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RMSE and coverage. MSM performed slightly better compared to the na¨ıve method but
absolute bias clearly increased compared to Scenario 2. Coverage for some treatment effects
were poor as well. Our proposed method remained unbiased, produced a lower RMSE
compared to the other two methods, and reached nominal coverage under Scenario 3. All
methods behaved as expected under these three scenarios.
Table 4 shows the results with the sample size increased to 8,000, approximately the
sample size in our application. The simulation results for all three methods under Scenario
1 remained relatively similar. Under Scenario 2, an increase in sample size did not affect the
absolute bias of all three methods but, the coverage of the na¨ıve method was clearly affected
with huge decreases in the coverage for all parameters. Coverage for MSM and our proposed
method remained fairly similar. Finally, under Scenario 3, we observe once again that the
amount of bias for the three methods remained the same but, coverage for the na¨ıve method
and MSM decreased for most of the treatment effects when the sample size increased to
8,000. Coverage for our proposed method remained relatively similar to the results observed
for the sample size of 4,000. In summary, bias for the three methods was rather stable when
the sample size changed. However, if the method is poor in the estimation of the particular
treatment effect, increasing the sample size can cause large decreases in coverage.
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5 Determining the effect of a negative wealth shock
on cognitive score for Health and Retirement Study
subjects
5.1 Health and Retirement Study
To investigate the association between negative wealth shock and cognitive ability in late
middle aged US adults, we used data from the Health and Retirement Study (HRS). HRS
is a longitudinal study of US adults, enrolled at age 50 and older. These individuals have
been surveyed biennially since 1992 with detailed modules on financial status and health
(Sonnega et al., 2014).
We use HRS data collected from 1996 to 2002 for our analysis. Subjects were obtained
from the original HRS cohort, born in the years 1931-1941. Although data collection began
in 1992, consistent collection of a subject’s cognitive ability only began in 1996. Hence, we
excluded the data collected before 1996 and treated the variables collected in 1996 as the
baseline for our analysis. We excluded subjects who did not have longitudinal measurements
for net worth because we were unable to distinguish whether they have already experienced
a negative wealth shock. Subjects with zero or negative net worth at baseline were excluded
since we did not know if these subjects have lifelong asset poverty or experienced a negative
wealth shock prior to study entry. We also removed subjects who experienced a negative
wealth shock and death between 1992 to 1996. These subjects were removed because they
were no longer at risk for a negative wealth shock or death. There were 9,750 participants
in the original HRS cohort, and of these, 7,106 participants (72.9%) were eligible for this
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analysis. These participants consists of a representative sample of the 1996 US population
aged 55 to 65 who had not experienced a negative wealth shock in the previous five years.
5.1.1 Determining negative wealth shock
To determine whether a subject experienced a negative wealth shock from the previous follow-
up period to the current follow-up period, we first obtained data from the module assessing
net worth administered at every wave of HRS. Measured assets include housing value, net
value of businesses, individual retirement accounts, checking/savings accounts, certificates
of deposits and savings bonds, investment holdings, net value of vehicles, and the value of
any other substantial assets. From this asset total, debts were subtracted, including home
mortgages, other home equity loans, and unsecured debt values, like credit card balances,
student loans, and medical debts. Missing values for wealth were imputed at the level of
each asset or debt, using an unfolding bracket imputation method (Juster and Smith, 1997).
Wealth data were not imputed for those who do not participate in a given wave. Negative
wealth shock was measured and then dichotomized (yes or no) for each time point. Loss
of 75% or more of total wealth between two consecutive waves was used as the cut-point
for negative wealth shock (Pool et al., 2017). Subjects were considered at risk for negative
wealth shock until they have experienced a negative wealth shock or reached age 65.
5.1.2 Cognitive ability
The cognitive ability of a subject is assessed in HRS using the Telephone Interview for
Cognitive Status (TICS). Unfortunately, the full HRS cognitive battery is not available for
participants under 65. Hence, we used an abbreviated measure that included questions
26
about episodic memory (Immediate Word recall [10 points] and Delayed Word recall [10
points]) and mental status (Serial 7’s [5 points], backwards counting from 20 [2 points])
(Crimmins et al., 2011). All responses were combined to create a composite score ranging
from 0 to 27, with a higher score indicating higher cognitive ability. Some of these measures
may be imputed implying that the cognitive summary score may include one or more imputed
scores (Fisher et al., 2018). We treated this measure as continuous and normally distributed.
5.1.3 Descriptive statistics at baseline
Tables 5 to 6 show the descriptive statistics of the subjects at baseline by whether or not they
experienced a negative wealth shock over the next six years regardless of survival status. At
baseline, aside from whether the subject eventually survived until 2002 and health conditions
like whether the subject ever had heart problems, high blood pressure, and stroke, all the
other variables in Tables 5 to 6 were significantly associated with experiencing a negative
wealth shock. A typical subject who would eventually experience a wealth shock would have a
lower cognitive score at baseline; slightly higher BMI; lower opinion about his or her health;
lower word recall score; likely still smoking; not insured; have depression; slightly lower
income; either working, unemployed, or disabled; divorced or never married; lower wealth
rank; have diabetes and/or psychological problems; younger; lesser years of education; and
likely non-White.
Table 7 shows the change in unadjusted mean cognitive score between consecutive
waves for subjects who did not receive a wealth shock versus those who ever received a
negative wealth shock. Follow-up surveys occurred at years 2, 4, and 6. We can see that
for a subject who ever got shocked, the largest observed decline in cognitive score occurs
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from Baseline to Wave 1. Subsequently, the decline in cognitive score is no longer as large
between waves. Similarly, the bulk of our subjects were shocked at Wave 1 (second year of
follow up). In later waves, the proportion of new subjects who received a negative wealth
shock decreases.
5.2 Analysis
We were interested in how a negative wealth shock would affect the cognitive ability of late
middle aged adults in the HRS during the six years of follow-up as well as how the duration
of a negative wealth shock affects cognitive ability accounting for missingness in the cognitive
outcome as well as censoring by death. We employed four different methods to estimate this
effect and make inference. The four methods were the na¨ıve method, where all subjects who
died under their observed negative wealth shock status were removed from analysis; baseline
adjusted method, where similar to the na¨ıve method, all subjects who died were removed
from analysis but the mean cognitive score was adjusted using a model that included all
baseline covariates; MSM, where negative wealth shock allocation, missingness, and censor-
ing by death were accounted for by inverse probability weighting; and our proposed method
including the PENCOMP modification described in Subsection 3.2. We assumed that de-
pression was the time-varying covariate that depends on the negative wealth shock status
(XZ1,...,Zt in Section 2) and the rest of the time-varying covariates are: self-reported health
status, whether subject was insured, labor force status of subject, income, level of alcohol
consumption, current smoking status, and number of health conditions (Wt in Section 3).
We also assumed that the cognitive score is missing at random given the baseline variables
presented in Tables 5 to 6, past negative wealth shock status, time-varying covariates, and
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cognitive score. For MSM, we accounted for this missingness by modeling the propensity of
response while for our proposed method, we imputed the missing cognitive score by using
the modified version of PENCOMP discussed in Subsection 3.2. All our models (baseline ad-
justed, MSM, and our proposed method) were specified using BART. For the na¨ıve, baseline
adjusted, and MSM method, we employed 1,000 bootstrap samples to calculate the mean
and the 95% Confidence Interval (CI). The 95% CI was determined by taking the 2.5 and
97.5 percentile. For our proposed method, we estimated the effect and accounted for our
uncertainty using our algorithm described in Subsection 3.2.
5.3 Results
Table 8 shows the adjusted effect estimate of a negative wealth shock on cognitive score
depending on the duration of the shock for late middle aged adults in the original HRS
cohort from 1996 to 2002. In general, the na¨ıve and baseline adjusted method suggests that
experiencing a negative wealth shock has a much larger negative effect on the cognitive score
of subjects in our sample compared to the adjusted estimates reported by MSM and our
proposed method. The na¨ıve and baseline adjusted method produced very similar results
suggesting low association between cognitive score and the baseline covariates. The effect
for subjects who experienced a negative wealth shock within the first 2 years of follow up
versus no shock (6 years vs. no shock), subjects who experienced a negative wealth shock
within the first 2 years of follow up versus subjects who experienced a negative wealth shock
between the second and fourth year of follow up (6 years vs. 2 years), and subjects who
experienced a negative wealth shock within the first 2 years of follow up versus subjects who
experienced a negative wealth shock between the fourth and sixth year of follow up (6 years
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vs. no shock), were significantly larger than 0 under the na¨ıve and baseline adjusted method.
For MSM and our proposed method all effects were reported to be not significant.
6 Discussion
In this paper, we were interested in how a negative wealth shock affects the cognitive ability
of late middle aged Americans participating in the HRS from 1996 to 2002. The main
difficulty we faced was the presence of death in some subjects causing their cognitive score
to be censored. Under situations where we believe death does not depend on the cognitive
ability or whether a subject received a negative wealth shock, removing subjects who have
died from our analysis would yield an unbiased estimate of the effect of negative wealth shock
on cognitive ability as our simulation results suggest. Unfortunately, it is very possible that
subjects with lower cognitive ability and/or have experienced a negative wealth shock would
have a higher risk of death. In this situation, accounting for the censoring by death would be
needed. This is because without randomization, there is a high likelihood that the proportion
of deaths between subjects who did not receive a negative wealth shock versus those who
received a wealth shock, would be imbalanced. In addition, subjects who die are more likely
to have a lower cognition score. As a result, if we remove the subjects who died from our
analysis, the effect of the negative wealth shock on cognitive ability that we measure would
be confounded by death. Although MSM is commonly employed to weight the subjects who
survived, this approach is arguably not sensible and would likely produce biased estimates
when the effect depends on the principal strata as well as when adjustments on the weights
have to be employed in order to stabilize the MSM estimate. To overcome these issues, we
propose a new method to estimate the effect by imputing the counterfactual survival status
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of each subject in order to compare outcomes among individuals who would survive only
under both sets of treatments being considered. Our method remained unbiased for all the
simulation scenarios we tried and produced reasonable coverage. When applied to the HRS
dataset, our method suggested that the effect of a negative wealth shock on the cognitive
ability is close to null whereas the na¨ıve method and MSM suggested an estimate with a
slightly larger effect.
One shortcoming of our approach is our failure to incorporate the HRS sample de-
sign, in particular the sampling weights, in our inference. Given that a key use of weights in
regression-type analysis is to reduce the effect of model misspecification (Korn and Graubard,
1995), we hope that our use of BART will minimize the degree of model misspecification.
We leave the incorporation of such features in a general approach to future work. Another
aspect of our method which could be improved is to allow our method to be applicable to
studies where the follow-up time is not fixed. In such a situation, Cox based survival models
would have to be employed and time would have to be included as a covariate in the survival
and outcome models. The difficulty in this extension would be how to develop a systematic
way, applicable to all subjects, to determine the relation in time between the allocation of
the treatment, measuring the outcome, and death.
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Table 1: Sample example of a censoring by death dataset until t = 3 where Zt = 1 indicates a subject having experienced a negative
wealth shock and Zt = 0 indicates a subject have not experienced any negative wealth shock till time t
V Z1 Y1 Y0 S1 S0 Z2 Y00 Y01 Y11 S00 S01 S11 Z3 Y000 Y001 Y011 Y111
Subject 1 x 1 x ? 1 1 1 ? ? x 1 1 1 1 ? ? ? x
Subject 2 x 0 ? x 1 1 1 ? x ? 1 1 1 1 ? ? x ?
Subject 3 x 1 x ? 1 1 1 ? ? x 1 1 0 NA ? ? ? NA
Subject 4 x 0 ? x 1 1 1 ? x ? 1 1 0 1 ? ? x NA
Subject 5 x 0 ? x 1 1 0 x ? ? 1 0 1 0 x ? NA ?
Subject 6 x 0 ? x 1 1 0 x ? ? 0 1 1 NA NA NA ? ?
Subject 7 x 0 ? x 1 1 0 x ? ? 0 1 1 NA NA NA ? ?
Subject 8 x 0 ? x 1 1 0 x ? ? 1 0 0 0 x ? NA NA
Subject 9 x 1 x ? 0 1 NA ? ? NA 1 1 0 NA ? ? ? NA
Subject 10 x 1 x ? 0 1 NA ? ? NA 0 1 0 NA NA NA ? NA
Subject 11 x 0 ? x 0 1 1 ? x NA 0 1 0 1 NA NA x NA
Subject 12 x 0 ? x 0 1 0 x ? NA 0 1 0 NA NA NA ? NA
Subject 13 x 1 x ? 1 0 1 NA NA x 0 0 1 1 NA NA NA x
Subject 14 x 0 ? x 1 0 NA NA NA ? 0 0 1 NA NA NA NA ?
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Table 2: Table of parameters for simulation
Scenario 1 Scenario 2 Scenario 3
V N(0, 22) N(17, 22) N(17, 22)
γ0 0 2 2
γ1 -0.02 -0.2 -0.2
β0 0 5.3 5.3
βZ -1.5 -1.5 -1.5
βV 0.015 0.15 0.2
βV Z -0.005 -0.11 -0.05
α0 0 1 0
αY1
0.005 0.00625 0.0625
αY0
0.01 0.0125 0.125
αZ -0.01 -0.2 -0.2
αV 0.002 0.02 0.02
αV Z -0.002 -0.02 -0.02
γ2 -0.002 -0.02 -0.02
γY0,2
-0.02 -0.2 -0.2
βZ01
-1.5 -1.5 -1.5
βZ11
-1 -1 -1
βY0Z00
0.015 0.02 0.3
βY0Z01
0.01 0.015 0.2
βY1Z11
0.005 0.01 0.1
βV Z01
-0.00011 -0.011 -0.011
βV Z11
-0.00005 -0.005 -0.005
αZ01
-0.01 -0.2 -0.2
αZ11
-0.015 -0.1 -0.1
αY0Z00
0.01 0.0125 0.125
αY0Z01
0.005 0.00625 0.0625
αY1Z11
0.0025 0.003125 0.03125
αV Z01
-0.0001 -0.02 -0.02
αV Z11
-0.0005 -0.05 -0.05
γ3 -0.0002 -0.002 -0.002
γY0,3
-0.002 -0.02 -0.02
γY00
-0.02 -0.2 -0.2
βZ001
-1.5 -1.5 -1.5
βZ011
-1 -1 -1
βZ111
-0.5 -0.5 -0.5
βY00Z000
0.015 0.02 0.3
βY00Z001
0.01 0.015 0.2
βY01Z011
0.005 0.01 0.1
βY11Z111
0.0025 0.005 0.05
βY0Z0
0.0008 0.08 0.08
βY1Z1
0.0003 0.03 0.03
βV Z001
-0.00011 -0.011 -0.011
βV Z011
-0.00005 -0.005 -0.005
βV Z111
-0.00003 -0.003 -0.003
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Table 3: Simulation results for sample size 4,000
Scenario 1 Na¨ıve MSM Proposed
Parameter True value Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL
∆1,0 -1.497 -0.001 0.032 95.4 0.123 -0.0002 0.032 95.1 0.123 -0.0001 0.032 97.0 0.143
∆01,00 -1.499 -0.003 0.050 95.3 0.202 -0.003 0.050 95.3 0.202 -0.003 0.050 95.7 0.214
∆11,00 -1.005 -0.003 0.049 95.0 0.189 -0.001 0.049 94.7 0.189 -0.001 0.049 99.2 0.262
∆11,01 0.493 0.002 0.048 94.4 0.189 0.003 0.048 94.5 0.189 0.002 0.049 99.1 0.262
∆001,000 -1.502 0.005 0.081 93.9 0.314 0.005 0.081 98.9 0.411 0.005 0.082 94.6 0.333
∆011,000 -1.008 0.004 0.074 94.8 0.284 0.004 0.074 99.0 0.370 0.004 0.075 97.8 0.350
∆111,000 -0.504 0.006 0.072 95.2 0.284 0.007 0.072 99.4 0.371 0.007 0.074 100.0 0.529
∆011,001 0.495 -0.001 0.071 95.0 0.284 -0.0001 0.072 99.1 0.370 -0.0009 0.072 97.8 0.348
∆111,001 1.000 -0.0001 0.072 95.6 0.284 0.001 0.072 99.0 0.371 0.001 0.074 99.9 0.528
∆111,011 0.502 0.003 0.065 94.3 0.250 0.005 0.065 98.9 0.325 0.005 0.067 99.9 0.440
Scenario 2 Na¨ıve MSM Proposed
Parameter True value Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL
∆1,0 -3.367 -0.047 0.061 78.5 0.154 0.002 0.041 93.8 0.160 0.002 0.041 96.1 0.177
∆01,00 -1.727 -0.037 0.054 83.2 0.149 -0.032 0.051 86.9 0.150 -0.002 0.037 96.4 0.161
∆11,00 -1.199 -0.136 0.146 24.5 0.202 -0.020 0.057 92.5 0.204 -0.004 0.053 96.5 0.229
∆11,01 0.528 -0.098 0.111 49.2 0.199 0.013 0.054 93.7 0.201 -0.001 0.053 97.0 0.226
∆001,000 -1.727 -0.029 0.062 91.9 0.220 -0.023 0.060 94.8 0.240 0.001 0.053 96.1 0.227
∆011,000 -1.183 -0.065 0.082 75.0 0.199 -0.047 0.069 87.5 0.217 0.0004 0.048 97.8 0.220
∆111,000 -1.169 -0.167 0.181 33.8 0.273 -0.042 0.084 93.2 0.305 -0.004 0.071 98.7 0.350
∆011,001 0.544 -0.036 0.059 88.0 0.185 -0.024 0.053 94.4 0.202 -0.002 0.045 96.7 0.206
∆111,001 0.558 -0.139 0.153 45.7 0.264 -0.019 0.071 96.3 0.294 -0.007 0.067 98.4 0.331
∆111,011 0.013 -0.101 0.119 62.9 0.246 0.007 0.065 96.1 0.276 -0.002 0.063 98.1 0.299
Scenario 3 Na¨ıve MSM Proposed
Parameter True value Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL
∆1,0 -2.347 -0.123 0.130 14.5 0.160 0.002 0.042 94.0 0.160 0.002 0.042 95.9 0.177
∆01,00 -2.559 -0.114 0.122 23.9 0.165 -0.060 0.074 70.2 0.164 -0.001 0.038 96.4 0.163
∆11,00 -3.062 -0.231 0.239 2.8 0.232 -0.033 0.068 89.9 0.226 -0.004 0.058 97.0 0.260
∆11,01 -0.502 -0.118 0.132 48.9 0.233 0.026 0.065 92.2 0.227 -0.003 0.059 96.7 0.260
∆001,000 -2.820 -0.125 0.139 47.9 0.242 -0.062 0.087 88.7 0.273 -0.0004 0.054 95.9 0.224
∆011,000 -3.605 -0.143 0.152 19.6 0.198 -0.087 0.101 69.2 0.225 -0.006 0.045 96.4 0.202
∆111,000 -4.032 -0.290 0.301 5.2 0.319 -0.082 0.117 89.4 0.376 -0.009 0.080 98.6 0.400
∆011,001 -0.785 -0.019 0.060 93.3 0.225 -0.026 0.063 95.0 0.256 -0.006 0.052 96.7 0.226
∆111,001 -1.217 -0.160 0.181 54.4 0.336 -0.015 0.087 97.2 0.396 -0.009 0.083 99.3 0.442
∆111,011 -0.432 -0.141 0.160 54.9 0.306 0.011 0.080 97.4 0.363 -0.006 0.075 98.7 0.373
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Table 4: Simulation results for sample size 8,000
Scenario 1 Na¨ıve MSM Proposed
Parameter True value Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL
∆1,0 -1.497 -0.001 0.023 94.2 0.087 0.0003 0.023 94.0 0.087 0.0003 0.023 96.2 0.100
∆01,00 -1.499 -0.002 0.036 95.3 0.143 -0.001 0.036 94.8 0.143 -0.001 0.037 95.5 0.151
∆11,00 -1.005 -0.002 0.034 94.8 0.134 -0.0007 0.034 95.1 0.134 -0.001 0.035 98.7 0.183
∆11,01 0.493 0.001 0.034 94.6 0.134 0.002 0.034 94.4 0.134 0.002 0.035 98.6 0.184
∆001,000 -1.502 0.005 0.057 95.0 0.222 0.005 0.057 99.0 0.289 0.005 0.058 95.4 0.235
∆011,000 -1.008 0.004 0.051 94.5 0.201 0.004 0.051 98.4 0.260 0.004 0.052 97.1 0.246
∆111,000 -0.504 0.005 0.051 95.1 0.201 0.007 0.052 98.3 0.261 0.006 0.053 99.7 0.369
∆011,001 0.495 -0.002 0.051 94.6 0.200 -0.002 0.051 99.1 0.260 -0.002 0.052 97.8 0.247
∆111,001 1.000 -0.001 0.052 94.2 0.201 0.0001 0.052 98.7 0.261 -0.0005 0.054 99.8 0.369
∆111,011 0.502 0.003 0.046 93.8 0.177 0.004 0.047 98.4 0.229 0.004 0.048 99.8 0.308
Scenario 2 Na¨ıve MSM Proposed
Parameter True value Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL
∆1,0 -3.367 -0.047 0.055 59.6 0.109 0.002 0.029 94.0 0.113 0.003 0.029 95.9 0.125
∆01,00 -1.727 -0.036 0.045 73.4 0.105 -0.031 0.041 78.8 0.106 -0.001 0.026 96.1 0.113
∆11,00 -1.199 -0.134 0.139 4.0 0.142 -0.018 0.041 92.4 0.144 -0.001 0.036 96.9 0.161
∆11,01 0.528 -0.098 0.105 21.9 0.140 0.013 0.038 94.0 0.142 -0.001 0.036 97.4 0.158
∆001,000 -1.727 -0.029 0.049 87.9 0.156 -0.024 0.047 93.2 0.170 0.0001 0.038 96.2 0.160
∆011,000 -1.183 -0.066 0.075 54.3 0.141 -0.048 0.060 77.7 0.153 -0.001 0.036 97.7 0.156
∆111,000 -1.169 -0.166 0.173 7.8 0.193 -0.040 0.065 90.4 0.215 -0.003 0.049 98.9 0.246
∆011,001 0.544 -0.038 0.050 81.5 0.131 -0.025 0.042 92.1 0.142 -0.002 0.032 97.2 0.145
∆111,001 0.558 -0.137 0.145 17.3 0.186 -0.017 0.050 96.7 0.208 -0.005 0.046 98.7 0.233
∆111,011 0.013 -0.098 0.108 38.0 0.174 0.010 0.046 96.4 0.194 0.0004 0.044 98.2 0.210
Scenario 3 Na¨ıve MSM Proposed
Parameter True value Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL Bias RMSE 95% Coverage AIL
∆1,0 -2.347 -0.123 0.126 1.5 0.113 0.002 0.029 94.5 0.113 0.003 0.029 95.7 0.124
∆01,00 -2.559 -0.114 0.118 3.4 0.117 -0.060 0.067 49.3 0.113 -0.001 0.028 96.1 0.115
∆11,00 -3.062 -0.230 0.234 0.1 0.164 -0.032 0.052 86.5 0.159 -0.004 0.040 97.3 0.183
∆11,01 -0.502 -0.118 0.125 19.4 0.164 0.026 0.048 91.0 0.160 -0.003 0.040 98.2 0.184
∆001,000 -2.820 -0.125 0.133 16.6 0.171 -0.063 0.076 78.3 0.192 -0.002 0.039 95.6 0.157
∆011,000 -3.605 -0.143 0.147 2.2 0.140 -0.087 0.093 40.8 0.159 -0.007 0.032 96.7 0.142
∆111,000 -4.032 -0.290 0.296 0.1 0.225 -0.081 0.099 81.5 0.265 -0.010 0.057 98.7 0.282
∆011,001 -0.785 -0.018 0.044 93.4 0.159 -0.024 0.047 94.7 0.181 -0.005 0.037 97.0 0.161
∆111,001 -1.217 -0.160 0.171 22.4 0.238 -0.013 0.062 97.1 0.278 -0.008 0.059 98.7 0.311
∆111,011 -0.432 -0.142 0.152 26.4 0.216 0.011 0.056 97.9 0.255 -0.006 0.052 98.7 0.264
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Table 5: Descriptive statistics of 1996 Health and Retirement Study (baseline), part 1
No wealth shock Ever wealth shock
Variables Mean/Frequency (S.E./%) Mean/Frequency (S.E./%) p-value
Eventually survived?: 0.57
Yes 6,207 (94.7) 516 (94.0)
No 350 (5.3) 33 (6.0)
Cognitive score 17.07 (4.07) 16.26 (4.35) < 0.01
BMI 27.21 (4.84) 27.73 (5.40) 0.03
Self-reported health < 0.01
Excellent 1,207 (19.9) 83 (15.7)
Very Good 2,126 (35.0) 128 (24.3)
Good 1,715 (28.2) 163 (30.9)
Fair 763 (12.6) 103 (19.5)
Poor 261 (4.3) 50 (9.5)
Current Smoking status: < 0.01
Never 2,353 (40.0) 166 (32.4)
Former 2,410 (41.0) 187 (36.5)
Current 1,116 (19.0) 159 (31.1)
Alcohol consumption: < 0.01
Never 3,799 (62.9) 347 (66.1)
Moderate 1,686 (27.9) 116 (22.1)
Heavy 555 (9.2) 62 (11.8)
Insured?: < 0.01
No 1,014 (15.5) 120 (21.9)
Yes 5,543 (84.5) 429 (78.1)
Depression?: < 0.01
No 4,922 (85.5) 361 (73.1)
Yes 832 (14.5) 133 (26.9)
Income (log transformed) 10.48 (1.21) 10.18 (1.45) < 0.01
Labor force status: < 0.01
Working 3,111 (51.2) 314 (59.6)
Unemployed 96 (1.6) 13 (2.5)
Retired 2,178 (35.9) 104 (19.7)
Disabled 143 (2.4) 43 (8.2)
Not in labor force 547 (9.0) 53 (10.1)
Martial status: < 0.01
Married 4,897 (80.8) 373 (70.8)
Divorced 591 (9.7) 90 (17.1)
Widowed 426 (7.0) 42 (8.0)
Never Married 149 (2.5) 22 (4.2)
Wealth rank in tertiles: < 0.01
0 1,728 (26.4) 326 (59.4)
1 2,360 (36.0) 124 (22.6)
2 2,469 (37.7) 99 (18.0)
Gender: 0.08
Male 3,113 (47.5) 239 (43.5)
Female 3,444 (52.5) 310 (56.5)
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Table 6: Descriptive statistics of 1996 Health and Retirement Study (baseline), part 2
No wealth shock Ever wealth shock
Variables Mean/Frequency (S.E./%) Mean/Frequency (S.E./%) p-value
Ever had diabetes?: < 0.01
No 5,474 (90.2) 451 (85.6)
Yes 596 (9.8) 76 (14.4)
Ever had heart problems?: 0.43
No 5,343 (88.0) 457 (86.7)
Yes 730 (12.0) 70 (13.3)
Ever had HBP?: 0.07
No 3,888 (64.0) 316 (60.0)
Yes 2,183 (36.0) 211 (40.0)
Ever had psych problems?: < 0.01
No 5,691 (93.7) 469 (89.2)
Yes 380 (6.3) 57 (10.8)
Ever had stroke?: 0.1
No 5,912 (97.3) 506 (96.0)
Yes 161 (2.7) 21 (4.0)
Age 59.73 (3.19) 57.26 (2.18) < 0.01
Number of education years centered 0.52 (2.93) -0.17 (3.32) < 0.01
Race: < 0.01
Non-hispanic White 5,236 (79.9) 342 (62.3)
Non-hispanic Black 759 (11.6) 120 (21.9)
Hispanic 449 (6.8) 70 (12.8)
Other 113 (1.7) 17 (3.1)
Table 7: Change in unadjusted cognitive score between consecutive waves stratified by neg-
ative wealth shock status
Never shocked Ever shocked Change in proportion shocked
Baseline to Wave 1 0.19 -1.61 3.5%
Wave 1 to Wave 2 -0.55 0.06 2.1%
Wave 2 to Wave 3 -0.05 -0.10 1.3%
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Table 8: Effect estimate of negative wealth shock on cognitive score for late middle aged adults in original Health Retirment Study
cohort from 1996 to 2002.
Na¨ıve Baseline adjusted† MSM* Proposed*
Estimate 95% CI Estimate 95% CI Estimate 95% CI Estimate 95% CI
2 years vs. no shock -0.51 (-1.45, 0.35) -0.51 (-1.37, 0.3) -0.01 (-1.18, 1.07) -0.13 (-0.83, 0.58)
4 years vs. no shock -0.69 (-1.45, 0.05) -0.7 (-1.4, 0.03) -0.31 (-1.23, 0.58) 0.18 (-0.73, 1.09)
6 years vs. no shock -1.95 (-2.62, -1.25) -1.94 (-2.6, -1.26) -0.12 (-1.12, 0.89) -0.18 (-0.87, 0.51)
4 years vs. 2 years -0.18 (-1.33, 1.04) -0.19 (-1.26, 0.94) -0.3 (-1.78, 1.15) 0.31 (-0.58, 1.20)
6 years vs. 2 years -1.45 (-2.54, -0.38) -1.43 (-2.46, -0.4) -0.1 (-1.61, 1.36) -0.03 (-0.83, 0.78)
6 years vs. 4 years -1.26 (-2.27, -0.2) -1.24 (-2.2, -0.24) 0.19 (-1.11, 1.61) -0.38 (-1.36, 0.61)
*Adjusted by gender, education category, race, cognitive score, BMI, self-reported health status, alcohol consumption, insurance status, depression status,
income, labor force status, marital status, age, smoking status, diabetes status, heart condition, HBP status, psychological problem status, and stroke status
at baseline as well as time-varying self-reported health status, alcohol consumption, insurance status, income, labor force status, smoking status, number of
health conditions, and depression.
†Adjusted by gender, education category, race, cognitive score, BMI, self-reported health status, alcohol consumption, insurance status, depression status,
income, labor force status, marital status, age, smoking status, diabetes status, heart condition, HBP status, psychological problem status, and stroke status
at baseline.
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